Henrik Loft
Valby, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Effectiveness of Vortioxetine for the Treatment of Emotional Blunting in Patients with Major Depressive Disorder Experiencing Inadequate Response to SSRI/SNRI Monotherapy in Spain: Results from the COMPLETE Study.
Journal: Neuropsychiatric disease and treatment
Published: June 14, 2024
Clinical benefits of vortioxetine 20 mg/day in patients with major depressive disorder.
Journal: CNS spectrums
Published: April 18, 2023
The Motivation and Energy Inventory (MEI): Analysis of the clinically relevant response threshold in patients with major depressive disorder and emotional blunting using data from the COMPLETE study.
Journal: Journal of affective disorders
Published: June 15, 2022
Vortioxetine in patients with major depressive disorder and high levels of anxiety symptoms: An updated analysis of efficacy and tolerability.
Journal: Journal of affective disorders
Published: June 01, 2022
Endocannabinoid Modulation Using Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A Phase 1 Randomized, Placebo-Controlled Study.
Journal: Pharmacopsychiatry
Published: November 30, 2021
Vortioxetine 20 mg/day in patients with major depressive disorder: updated analysis of efficacy, safety, and optimal timing of dose adjustment.
Journal: CNS spectrums
Published: October 18, 2021
Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A 12-Week, Randomized, Controlled Study.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: February 24, 2021
Validation of the Oxford Depression Questionnaire: Sensitivity to change, minimal clinically important difference, and response threshold for the assessment of emotional blunting.
Journal: Journal of affective disorders
Published: February 03, 2021
Efficacy of Vortioxetine on Anhedonia: Results from a Pooled Analysis of Short-Term Studies in Patients with Major Depressive Disorder.
Journal: Neuropsychiatric disease and treatment
Published: December 15, 2020
Effectiveness of Vortioxetine on Emotional Blunting in Patients with Major Depressive Disorder with inadequate response to SSRI/SNRI treatment.
Journal: Journal of affective disorders
Published: July 02, 2020
Successfully treated patients with vortioxetine versus venlafaxine: a simplified cost-effectiveness analysis based on a head-to-head study in Asian patients with major depressive disorder.
Journal: Current medical research and opinion
Published: January 29, 2020
Efficacy of vortioxetine in patients with major depressive disorder reporting childhood or recent trauma.
Journal: Journal of affective disorders
Published: July 15, 2019
Last Updated: 09/26/2026